Caption Management, LLC Aerie Pharmaceuticals Inc Transaction History

Caption Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$15.16 - $18.97 $1.42 Million - $1.78 Million	-93,808 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$13.12 - $20.9 $1.23 Million - $1.96 Million	93,808 New	93,808 $1.68 Million
Q2 2020 Aug 14, 2020	SELL	$12.0 - $16.13 $960,000 - $1.29 Million	-80,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$11.84 - $25.52 $651,200 - $1.4 Million	55,000 Added 220.0%	80,000 $1.08 Million
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $460,250 - $700,000	25,000 New	25,000 $480,000
Q3 2018 Nov 14, 2018	SELL	$56.15 - $73.9 $2.19 Million - $2.88 Million	-39,000 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$47.85 - $70.45 $1.87 Million - $2.75 Million	39,000 New	39,000 $2.64 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.